Bimatoprost

At latest update no published data on excretion into breast milk were found.

The small dose and low plasma absorption of most topical ophthalmic preparations make it unlikely the passage of significant amount of such a product to breast milk, so the use as ophthalmic eye drops poses a very low risk while breastfeeding.
In addition, its short half-life and high plasma protein binding capacity make it even more unlikely any passage to the breast milk.

After application, press onto the tear sac or close the eyelids tightly for a couple of minutes (nasolacrimal occlusion) to minimize systemic absorption.

Alternatives

We do not have alternatives for Bimatoprost since it is relatively safe.